SCHEMBL6003264

SCHEMBL6003264

COc1ccc2c(C(=O)c3ccc(OCCC4CCCCN4)cc3)c(-c3c(F)ccc(F)c3F)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.43
SSTR2 P30874 4/20 0.37
AURKB Q96GD4 1/20 0.36
KDM2B Q8NHM5 2/20 0.36
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
PHLPP2 Q6ZVD8 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
GNRHR P30968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6004684 0.99 CHEK2 (0.42) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6005446 0.94 CHEK2 (0.44) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6005426 0.93 CHEK2 (0.43) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6005698 0.92 CHEK2 (0.43) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6004732 0.91 CHEK2 (0.43) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6003358 0.91 CHEK2 (0.43) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6003280 0.90 CHEK2 (0.43) CHEK2ESR1ESR2
SCHEMBL6004611 0.90 CHEK2 (0.43) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6003307 0.89 CHEK2 (0.43) CHEK2SSTR2AURKBKDM2BESR1
SCHEMBL6005363 0.88 CHEK2 (0.42) CHEK2SSTR2AURKBKDM2BESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed